Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
Matthias Wölfl, Philip D. Greenberg
Nature Protocols (2014) Vol. 9, Iss. 4, pp. 950-966
Open Access | Times Cited: 130

Showing 51-75 of 130 citing articles:

Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition
Xiaojian Han, Xiaxia Han, Yanan Hao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation
Panagiota Maravelia, Hongyang Yao, Curtis Cai, et al.
Gut (2025), pp. gutjnl-334148
Closed Access
MHC class I trafficking signal improves induction of cytotoxic T lymphocyte using artificial antigen presenting cells
Kenta Sasaki, Kenji Murata, Tomoyuki Minowa, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101946-101946
Closed Access
Large‐Scale Screening of CD4+ T‐Cell Epitopes From SARS‐CoV‐2 Proteins and the Universal Detection of SARS‐CoV‐2 Specific T Cells for Northeast Asian Population
Yu Zhao, Chengtao He, Min Peng, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapy
Zujian Xiong, Chaim Sneiderman, Chloe R Kuminkoski, et al.
Genes and Immunity (2025)
Closed Access
Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay
Heidi S. Schultz, Stine Louise Reedtz-Runge, B. Thomas Bäckström, et al.
PLoS ONE (2017) Vol. 12, Iss. 5, pp. e0178544-e0178544
Open Access | Times Cited: 39
Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy
Md. Selim Ahmed, Se Eun Byeon, Yideul Jeong, et al.
OncoImmunology (2015) Vol. 4, Iss. 1, pp. e984550-e984550
Open Access | Times Cited: 34
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells
Alexei F. Kirkin, Karine N. Dzhandzhugazyan, Per Guldberg, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial
Felix S. Lichtenegger, Frauke M. Schnorfeil, Maurine Rothe, et al.
Clinical & Translational Immunology (2020) Vol. 9, Iss. 3
Open Access | Times Cited: 31
Dendritic cell-mimicking scaffolds for ex vivo T cell expansion
Hye Sung Kim, Tzu‐Chieh Ho, Moshe J. Willner, et al.
Bioactive Materials (2022) Vol. 21, pp. 241-252
Open Access | Times Cited: 16
An in vitro CD8 T-cell priming assay enables epitope selection for hepatitis C virus vaccines
Georgia Koutsoumpli, Neringa Stasiukonyte, Baukje Nynke Hoogeboom, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126032-126032
Open Access | Times Cited: 3
T-Switch: A specificity-based engineering platform for developing safe and effective T cell therapeutics
Nouran S. Abdelfattah, Tomasz Kula, Stephen J. Elledge
Immunity (2024)
Closed Access | Times Cited: 3
Priming of Qualitatively Superior Human Effector CD8+ T Cells Using TLR8 Ligand Combined with FLT3 Ligand
Anna Lissina, Olivia Briceño, Georgia Afonso, et al.
The Journal of Immunology (2015) Vol. 196, Iss. 1, pp. 256-263
Open Access | Times Cited: 33
The Ways of Isolating Neoantigen-Specific T Cells
Qing Li, Zhenyu Ding
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 27
Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
Valérie Janelle, Cédric Carli, Julie Taillefer, et al.
Journal of Translational Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Tumor RNA transfected DCs derived from iPS cells elicit cytotoxicity against cancer cells induced from colorectal cancer patients in vitro
Shimpei Maruoka, Toshiyasu Ojima, Hiromitsu Iwamoto, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
MiR‐146a‐5p accelerates sepsis through dendritic cell activation and glycolysis via targeting ATG7
Junbo Yu, Jianhua Xue, Chun Liu, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 13
Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination
Sara E. Sabbagh, Dipica Haribhai, Jill A. Gershan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
A cancer vaccine approach for personalized treatment of Lynch Syndrome
Snigdha Majumder, Rakshit Shah, Jisha Elias, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations
Gerard Agbayani, Yimei Jia, Bassel Akache, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 9, pp. 2183-2195
Open Access | Times Cited: 18
Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy
Ariel Isser, Aliyah B. Silver, Hawley C. Pruitt, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Research progress of the engagement of inorganic nanomaterials in cancer immunotherapy
Tingwei Peng, Tianzhao Xu, Xinghui Liu
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1914-1932
Open Access | Times Cited: 11
Impact of Sequence Variation in a Dominant HLA-A*02-Restricted Epitope in Hepatitis C Virus on Priming and Cross-Reactivity of CD8 + T Cells
Susanne Ziegler, Kathrin Skibbe, Andreas Walker, et al.
Journal of Virology (2014) Vol. 88, Iss. 19, pp. 11080-11090
Open Access | Times Cited: 17
Peptide/MHC Tetramer–Based Sorting of CD8+ T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
Sally A. Hunsucker, Colleen S. McGary, Benjamin G. Vincent, et al.
Cancer Immunology Research (2015) Vol. 3, Iss. 3, pp. 228-235
Open Access | Times Cited: 16
IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing
Matthias Braun, Marie L. Reß, Youngeun Yoo, et al.
OncoImmunology (2016) Vol. 5, Iss. 7, pp. e1188245-e1188245
Open Access | Times Cited: 15

Scroll to top